A Milestone Investment in Manufacturing Excellence
Changzhou Newrise Medical & Hygiene Products Co., Ltd. is proud to announce a major expansion of its production capabilities in early 2026. The company has installed 10 new automated production lines at its 40,000㎡ manufacturing facility in Changzhou, Jiangsu Province, representing one of the largest capacity investments in the company's 22-year history.
This expansion brings Newrise Medical's total production lines to over 40, significantly increasing our ability to serve distributors, healthcare procurement teams, and OEM partners across more than 50 countries. The investment underscores our commitment to remaining a reliable, high-volume supplier in the global disposable medical products market.
"This expansion isn't just about making more products — it's about making more products at the same uncompromising quality standard our customers expect." — Newrise Medical Management Team
What the Expansion Includes
The 10 new production lines are designed for efficiency, precision, and scalability. Each line features state-of-the-art automation technology that reduces manual handling, improves consistency, and accelerates throughput. Here's a breakdown of the new capabilities:
| Production Line | Product Category | Key Improvement |
|---|---|---|
| Lines 1–3 | Incontinence Care Products | High-speed underpad and bed pad production with automated cutting and folding |
| Lines 4–5 | Disposable Medical Blankets | Multi-material blanket assembly with integrated packaging |
| Lines 6–7 | Patient Transfer Sheets | Precision cutting and handle attachment for transfer sheets |
| Lines 8–9 | Infection Control Products | Wash gloves, washcloths, and pre-moistened wipes with automated solution dosing |
| Line 10 | General Non-Woven Products | Flexible line for OEM and custom product manufacturing |
Why Now? Understanding the Market Dynamics
The decision to expand was driven by several converging market trends that have accelerated demand for disposable medical and hygiene products worldwide:
1. Growing Global Healthcare Demand
The aging global population and increasing awareness of infection prevention have driven sustained demand for single-use medical products. The global disposable medical supplies market is projected to exceed $150 billion by 2028, with Asia-Pacific being the fastest-growing region.
2. Post-Pandemic Infection Control Standards
Healthcare facilities worldwide have permanently elevated their infection control protocols. Single-use products — from wash gloves to patient transfer sheets — are now standard practice in hospitals that previously relied on reusable alternatives. This shift has created structural, long-term demand growth.
3. OEM Partner Expansion
Newrise Medical has seen a 40% year-over-year increase in OEM and private-label inquiries from distributors in North America, Europe, and Southeast Asia. The new production lines provide the flexibility and capacity to handle these growing partnership opportunities.
📊 Expansion at a Glance
- 10 new automated production lines installed and operational
- 30% increase in annual production capacity
- 40,000㎡ facility in Changzhou, Jiangsu — one of the largest in the region
- 100,000-class cleanroom (1,500㎡) for sterile product manufacturing
- ISO 13485:2016 certified quality management system across all lines
- CE and FDA registered products for global market access
Quality at Scale: The ISO 13485 Commitment
Capacity means nothing without quality. Newrise Medical operates under an ISO 13485:2016 certified quality management system, ensuring that every product — regardless of which production line it comes from — meets the same rigorous standards. Our quality control processes include:
- Raw material inspection — All incoming materials are tested against specifications before entering production
- In-process quality checks — Automated sensors and manual inspections at every stage of the production process
- Final product testing — Every batch is tested for dimensions, absorbency, strength, and sterility (where applicable) before release
- Traceability — Full batch-level traceability from raw material to finished product shipment
This commitment to quality is reflected in our CE marking and FDA registration, which are maintained across all product categories and production lines.
What This Means for Our Customers
For existing and prospective customers, this capacity expansion delivers several tangible benefits:
- Shorter lead times — Increased capacity means faster turnaround on orders, especially during peak demand periods
- Competitive pricing — Economies of scale from larger production runs translate to better pricing for our partners
- Greater product availability — Reduced risk of stock-outs and backorders on high-demand items
- Enhanced OEM capabilities — The new flexible production line enables faster prototyping and shorter sample lead times for custom products
- Consistent quality — More automated processes mean less variability and more consistent product performance
Looking Ahead: 2026 and Beyond
This production expansion is part of a broader growth strategy that includes continued investment in R&D, sustainability initiatives, and global market expansion. Newrise Medical is actively pursuing new product development in areas such as eco-friendly disposable products and advanced infection control solutions.
With over two decades of manufacturing experience, a modern facility, and now significantly expanded capacity, Newrise Medical is well-positioned to serve as a trusted, long-term supply partner for healthcare facilities and distributors worldwide.